docetaxel anhydrous has been researched along with Drug Hypersensitivity in 62 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 14 (22.58) | 18.2507 |
2000's | 20 (32.26) | 29.6817 |
2010's | 25 (40.32) | 24.3611 |
2020's | 3 (4.84) | 2.80 |
Authors | Studies |
---|---|
Costa, J; Jabaley, T; Lynch, DM; Mazzola, E; Menon, S | 1 |
Bhutta, OA; Khan, I; Masood, W; Saleem, Z; Shammas, S | 1 |
Biedermann, S; Colevas, AD; He, Z; Lansinger, OM | 1 |
Mahdi, H; Maurer, K; Michener, C; Rose, PG | 1 |
Chen, Z; Cheng, H; He, Q; Li, C; Yang, Y; Zhang, M | 1 |
Picard, M | 1 |
Boggiani, D; Musolino, A; Palli, D; Pellegrino, B; Tommasi, C | 1 |
Wu, HL | 1 |
Bavbek, S; Bonadonna, P; Caralli, M; Castells, M; Cernadas, J; Cortellini, G; Costantino, MT; Dursun, AB; Gelincik, A; Lucchini, G; Pagani, M | 1 |
Bousquet, G; Hamdan, D; Janin, A; Le Foll, C; Leboeuf, C | 1 |
Armstrong, DK; Coleman, RL; Phillips, M; Weil, SC; White, AJ | 1 |
Gandara, DR; Groshen, S; Iqbal, S; Lenz, HJ; Newman, EM; Shibata, SI; Synold, TW | 1 |
Hawkins, C; Kuo, JC; Yip, D | 1 |
Chica Marchal, A; De Andrés Bautista, M; Ferris Villanueva, E; García Simón, MS; Guerrero Bautista, R; Pérez Cañadas, P | 1 |
Ageshio, F; Kagawa, H; Kimura, H; Matsui, H; Mori, M; Niinaka, M; Satomi, A; Uenami, T; Yamaguchi, T; Yano, Y; Yokota, S; Yoneda, T | 1 |
Berlin, ST; Caiado, J; Campos, SM; Castells, MC; Galvão, VR; Giavina-Bianchi, P; Matulonis, UA; Picard, M; Pur, L | 1 |
Bousquet, G; Hamdan, D; Janin, A; Jourdan, N; Leboeuf, C; Pereira, C; Verneuil, L | 1 |
Aapro, MS; Ajani, J; Baker, J; Martin, M; Scotté, F; von Minckwitz, G; Winther, D | 2 |
Chen, ZD; Pan, YY; Zhang, MJ | 1 |
Burris, HA; Greco, FA; Hainsworth, JD; Inhorn, RC; Lane, CM; Reeves, J; Rubinsak, J; Spigel, DR; Thompson, DS; Vazquez, ER; Webb, C | 1 |
Chouhan, JD; Herrington, JD | 1 |
Pagani, M | 1 |
Baricordi, OR; Ferlini, A; Indelli, M; Lelli, G; Rimessi, P; Rizzo, R; Spaggiari, F | 1 |
de Monchy, JG; Hiltermann, TJ; Luiting, J; Oude Elberink, JN | 1 |
Dannos, I; Dilana, K; Gkiozos, I; Kotteas, E; Makrilia, N; Saif, MW; Syrigos, KN; Syrigou, E; Tourkantonis, I | 1 |
Brown, JB; Kadoyama, K; Kuwahara, A; Okuno, Y; Sakaeda, T; Yamamori, M | 1 |
Alba, E; García-Tapiador, A; González-Sánchez, LA; Jiménez, B; Medina, L; Navarro, V; Romero-García, G; Sánchez-Muñoz, A | 1 |
Brockow, K; Ring, J; Seifert, F; Zink, A; Zirbs, M | 1 |
Callahan, MJ; Reeves, DJ; Sutton, GP | 1 |
de Vos, FY; van Laarhoven, HM | 1 |
Ando, M; Katsumata, N; Mukai, H; Watanabe, T | 1 |
Markman, M | 1 |
Demoly, P; Messaad, D; Pujol, JL; Sablayrolles, P | 1 |
Ardavanis, A; Baziotis, N; Gerasimidis, G; Rigatos, G; Tryfonopoulos, D; Yiotis, I | 1 |
Misawa, A; Misawa, H; Saitou, M; Ueta, K; Yasuda, M | 1 |
Akçay, S; Eyüboglu, FO; Karacan, O; Ozyilkan, O | 1 |
Castells, M; Feldweg, AM; Lee, CW; Matulonis, UA | 1 |
Barth, J | 1 |
Disilvestro, P; Dizon, DS; Gordinier, ME; Granai, CO; Legare, RD; Miller, J; Moore, R; Pires, L; Rojan, A; Schwartz, J | 1 |
Ballard, EE; Dowell, JE; Hunt, WC; Jumper, CA; Krieger, JA; Rabinowitz, I; Shah, SR; Stanford, BL | 1 |
Fumoleau, P; Lemevel, B; Maugard-Louboutin, C; Perrocheau, G | 1 |
Aamdal, S; Franklin, HR; Kaplan, S; Kerger, J; Paridaens, R; Schachter, J; Verweij, J; Wanders, J; Wolff, I | 1 |
Benner, S; Calayag, M; Fossella, FV; Glisson, B; Huber, M; Lee, JS; Lippman, S; Murphy, WK; Perez-Soler, R; Shin, DM | 1 |
Foa, R; Norton, L; Seidman, AD | 1 |
Eisenhauer, EA; Ernst, S; Jolivet, J; Mertens, WC; Moore, M; Muldal, A | 1 |
Abbruzzese, JL; Ajani, JA; Bready, B; Lassere, Y; Levin, B; Patt, Y; Pazdur, R; Soh, LT; Soo, E; Sugarman, S | 1 |
Gelmon, K | 1 |
Dirix, L; Kaye, S; Prove, A; Schrijvers, D; van Oosterom, A; Vonck, I; Wanders, J | 1 |
Balmaceda, C; Baselga, J; Bruno, R; Crown, JP; Currie, V; Freilich, R; Gilewski, TA; Gollub, M; Hakes, TB; Hudis, CA; Lebwohl, DE; Norton, L; Raptis, G; Robles, M; Seidman, AD | 1 |
Rodenhuis, S; ten Bokkel Huinink, WW; Westermann, AM | 1 |
Bajorin, DF; Hilton, S; Kelly, WK; Mazumdar, M; McCaffrey, JA; Sadan, S; Scher, HI | 1 |
Etienne, B; Guérin, JC; Nesme, P; Pérol, M; Robinet, G; Vuillermoz, S | 1 |
Anderson, N; Lokich, J | 1 |
Androulakis, N; Bahlitzanakis, N; Georgoulias, V; Giatromanolaki, A; Kakolyris, S; Kamilaki, M; Kotsakis, A; Koukouraki, S; Koukourakis, MI; Kourousis, C | 1 |
Briasoulis, E; Karavasilis, V; Pavlidis, N | 1 |
Bevers, M; Freedman, R; Kavanagh, JJ; Kudelka, AP; Moon, C; Verschraegen, CF | 1 |
Bernstein, BJ | 1 |
Belinson, J; Kennedy, A; Kulp, B; Markman, M; Peterson, G; Webster, K | 1 |
Markman, M; Zanotti, KM | 1 |
Abdi, EA; Denman, JP; Gilbar, PJ | 1 |
12 review(s) available for docetaxel anhydrous and Drug Hypersensitivity
Article | Year |
---|---|
Management of Hypersensitivity Reactions to Taxanes.
Topics: Allergens; Animals; Antineoplastic Agents; Bridged-Ring Compounds; Desensitization, Immunologic; Docetaxel; Drug Hypersensitivity; Humans; Paclitaxel; Skin Tests; Taxoids | 2017 |
Nab-paclitaxel after docetaxel hypersensitivity reaction: case report and literature review.
Topics: Aged; Albumins; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Ductal, Breast; Cross Reactions; Docetaxel; Drug Hypersensitivity; Female; Humans; Paclitaxel; Taxoids | 2017 |
Docetaxel-related side effects and their management.
Topics: Antineoplastic Agents; Asthenia; Docetaxel; Drug Administration Schedule; Drug Hypersensitivity; Drug Monitoring; Edema; Evidence-Based Practice; Humans; Nail Diseases; Neoplasms; Nervous System Diseases; Neutropenia; Nursing Assessment; Oncology Nursing; Patient Selection; Practice Guidelines as Topic; Quality of Life; Severity of Illness Index; Taxoids | 2009 |
The complex clinical picture of presumably allergic side effects to cytostatic drugs: symptoms, pathomechanism, reexposure, and desensitization.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Asparaginase; Carboplatin; Cisplatin; Cytostatic Agents; Desensitization, Immunologic; Docetaxel; Drug Hypersensitivity; Humans; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Procarbazine; Risk Factors; Taxoids; Teniposide | 2010 |
Managing taxane toxicities.
Topics: Antineoplastic Agents, Phytogenic; Arthralgia; Bridged-Ring Compounds; Docetaxel; Drug Hypersensitivity; Humans; Neutropenia; Paclitaxel; Peripheral Nervous System Diseases; Taxoids; Thrombocytopenia | 2003 |
[Administration of taxane-containing drugs].
Topics: Animals; Antineoplastic Agents, Phytogenic; Docetaxel; Drug Hypersensitivity; Drug Incompatibility; Drug Interactions; Humans; Taxoids | 2005 |
Docetaxel-related side effects and their management.
Topics: Antineoplastic Agents; Asthenia; Docetaxel; Drug Administration Schedule; Drug Hypersensitivity; Drug Monitoring; Evidence-Based Medicine; Fever; Humans; Nail Diseases; Neutropenia; Nurse's Role; Nursing Assessment; Nursing Research; Oncology Nursing; Patient Education as Topic; Peripheral Nervous System Diseases; Practice Guidelines as Topic; Premedication; Research Design; Severity of Illness Index; Taxoids; Water-Electrolyte Imbalance | 2008 |
[Paclitaxel (Taxol) and docetaxel (Taxotere): results of phase II trials in monochemotherapy].
Topics: Antineoplastic Agents, Phytogenic; Clinical Trials, Phase II as Topic; Docetaxel; Drug Administration Schedule; Drug Hypersensitivity; Drug Tolerance; Female; Humans; Male; Neoplasms; Neutropenia; Organoplatinum Compounds; Paclitaxel; Taxoids | 1995 |
Taxol (paclitaxel): a novel anti-microtubule agent with remarkable anti-neoplastic activity.
Topics: Animals; Antineoplastic Agents, Phytogenic; Arrhythmias, Cardiac; Cell Cycle; Clinical Trials as Topic; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Docetaxel; Drug Hypersensitivity; Drug Screening Assays, Antitumor; Gastrointestinal Diseases; Humans; Mice; Microtubules; Neoplasms; Neoplasms, Experimental; Neutropenia; Paclitaxel; Peripheral Nervous System Diseases; Polyethylene Glycols; Taxoids; Tubulin | 1994 |
The taxoids: paclitaxel and docetaxel.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Clinical Trials as Topic; Docetaxel; Drug Hypersensitivity; Drug Interactions; Female; Humans; Lung Neoplasms; Ovarian Neoplasms; Paclitaxel; Taxoids | 1994 |
Docetaxel as an alternative to paclitaxel after acute hypersensitivity reactions.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Clinical Trials as Topic; Docetaxel; Drug Hypersensitivity; Female; Humans; Lung Neoplasms; Middle Aged; Ovarian Neoplasms; Paclitaxel; Taxoids | 2000 |
Prevention and management of antineoplastic-induced hypersensitivity reactions.
Topics: Antineoplastic Agents; Asparaginase; Docetaxel; Drug Hypersensitivity; Humans; Neoplasms; Organoplatinum Compounds; Paclitaxel; Podophyllotoxin; Taxoids | 2001 |
16 trial(s) available for docetaxel anhydrous and Drug Hypersensitivity
Article | Year |
---|---|
Pretreatment with different doses of dexamethasone in the prevention of docetaxel-induced hypersensitivity.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Allergic Agents; Antineoplastic Agents; China; Dexamethasone; Docetaxel; Drug Administration Schedule; Drug Hypersensitivity; Female; Humans; Male; Middle Aged; Taxoids; Time Factors; Treatment Outcome; Young Adult | 2017 |
Role of Skin Tests in the Diagnosis of Immediate Hypersensitivity Reactions to Taxanes: Results of a Multicenter Study.
Topics: Adult; Aged; Antineoplastic Agents; Docetaxel; Drug Hypersensitivity; Female; Humans; Male; Middle Aged; Neoplasms; Paclitaxel; Skin Tests | 2019 |
Farletuzumab (a monoclonal antibody against folate receptor alpha) in relapsed platinum-sensitive ovarian cancer.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Ovarian Epithelial; Disease-Free Survival; Docetaxel; Drug Hypersensitivity; Fallopian Tube Neoplasms; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Taxoids | 2013 |
A phase I trial of oxaliplatin in combination with docetaxel in patients with advanced solid tumors.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Dose-Response Relationship, Drug; Drug Hypersensitivity; Female; Humans; Infusions, Intravenous; Male; Metabolic Clearance Rate; Middle Aged; Neoplasms; Neutropenia; Organoplatinum Compounds; Oxaliplatin; Severity of Illness Index; Taxoids; Tubulin Modulators | 2013 |
Phase II study of cetuximab, docetaxel, and gemcitabine in patients with previously untreated advanced non-small-cell lung cancer.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cetuximab; Deoxycytidine; Disease-Free Survival; Docetaxel; Drug Hypersensitivity; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Taxoids; Tennessee; Treatment Outcome | 2010 |
A randomized trial assessing the utility of a test-dose program with taxanes.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Cost Control; Docetaxel; Drug Hypersensitivity; Female; Humans; Male; Middle Aged; Neoplasms; Paclitaxel; Taxoids | 2005 |
Docetaxel (Taxotere) in advanced malignant melanoma: a phase II study of the EORTC Early Clinical Trials Group.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Docetaxel; Drug Hypersensitivity; Female; Humans; Male; Melanoma; Middle Aged; Paclitaxel; Taxoids | 1994 |
Phase II study of docetaxel for advanced or metastatic platinum-refractory non-small-cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents, Phytogenic; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Docetaxel; Drug Hypersensitivity; Drug Resistance; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neutropenia; Paclitaxel; Remission Induction; Survival Rate; Taxoids | 1995 |
Docetaxel in advanced renal carcinoma. A phase II trial of the National Cancer Institute of Canada Clinical Trials Group.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Docetaxel; Drug Hypersensitivity; Female; Humans; Kidney Neoplasms; Male; Middle Aged; Paclitaxel; Taxoids | 1994 |
Phase II trial of docetaxel (Taxotere) in metastatic colorectal carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Agranulocytosis; Antineoplastic Agents, Phytogenic; Colorectal Neoplasms; Docetaxel; Drug Administration Schedule; Drug Eruptions; Drug Hypersensitivity; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Paclitaxel; Taxoids | 1994 |
Coping with toxicities of docetaxel (Taxotere).
Topics: Antineoplastic Agents, Phytogenic; Cetirizine; Docetaxel; Drug Hypersensitivity; Edema; Humans; Ketotifen; Methylprednisolone; Paclitaxel; Skin Diseases; Taxoids | 1993 |
Phase II and pharmacologic study of docetaxel as initial chemotherapy for metastatic breast cancer.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cimetidine; Dexamethasone; Diphenhydramine; Docetaxel; Drug Administration Schedule; Drug Hypersensitivity; Edema; Female; Humans; Injections, Intravenous; Leukopenia; Middle Aged; Neoplasm Metastasis; Paclitaxel; Premedication; Taxoids | 1996 |
Phase II trial of docetaxel in patients with advanced or metastatic transitional-cell carcinoma.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Carcinoma, Transitional Cell; Docetaxel; Drug Hypersensitivity; Female; Humans; Male; Middle Aged; Paclitaxel; Remission Induction; Survival Analysis; Taxoids; Urologic Neoplasms | 1997 |
Weekly docetaxel and concomitant boost radiotherapy for non-small cell lung cancer. A phase I/II dose escalation trial.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Docetaxel; Dose-Response Relationship, Drug; Drug Hypersensitivity; Hematologic Diseases; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Radiation-Sensitizing Agents; Radiotherapy; Taxoids; Treatment Outcome | 1998 |
Successful rechallenge with taxanes following prophylactic ketotifen in patients who had developed severe hypersensitivity reactions.
Topics: Adult; Aged; Anti-Allergic Agents; Antineoplastic Agents, Phytogenic; Docetaxel; Drug Hypersensitivity; Female; Humans; Ketotifen; Male; Middle Aged; Neoplasms; Paclitaxel; Pilot Projects; Taxoids | 2000 |
Combination chemotherapy with carboplatin and docetaxel in the treatment of cancers of the ovary and fallopian tube and primary carcinoma of the peritoneum.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Docetaxel; Drug Hypersensitivity; Fallopian Tube Neoplasms; Female; Humans; Middle Aged; Neutropenia; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Taxoids | 2001 |
34 other study(ies) available for docetaxel anhydrous and Drug Hypersensitivity
Article | Year |
---|---|
A Three-Step Taxane Titration Protocol Decreases Hypersensitivity Reactions During First and Second Exposures.
Topics: Docetaxel; Drug Hypersensitivity; Epinephrine; Humans; Paclitaxel; Prospective Studies; Taxoids | 2023 |
Comparative study of oral and IV dexamethasone premedication in the prevention of docetaxel induced allergic reactions.
Topics: Dexamethasone; Docetaxel; Drug Hypersensitivity; Humans; Paclitaxel; Premedication; Retrospective Studies | 2022 |
Do Steroids Matter? A Retrospective Review of Premedication for Taxane Chemotherapy and Hypersensitivity Reactions.
Topics: Antineoplastic Agents, Phytogenic; California; Dexamethasone; Docetaxel; Drug Hypersensitivity; Drug Prescriptions; Drug Utilization; Electronic Health Records; Female; Humans; Male; Paclitaxel; Practice Patterns, Physicians'; Premedication; Retrospective Studies; Risk Assessment; Risk Factors; Steroids; Time Factors; Treatment Outcome | 2021 |
Universal tolerance of nab-paclitaxel for gynecologic malignancies in patients with prior taxane hypersensitivity reactions.
Topics: Adult; Aged; Albumins; Anemia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Cisplatin; Deoxycytidine; Docetaxel; Drug Hypersensitivity; Female; Gemcitabine; Genital Neoplasms, Female; Humans; Middle Aged; Nervous System Diseases; Neutropenia; Paclitaxel; Retreatment; Retrospective Studies; Taxoids; Thrombocytopenia | 2017 |
Retrospective evaluation of a rechallenge protocol in patients experiencing hypersensitivity reactions with prior chemotherapy in a tertiary hospital.
Topics: Adult; Aged; Antineoplastic Agents; Carboplatin; Docetaxel; Drug Hypersensitivity; Female; Humans; Male; Middle Aged; Oxaliplatin; Paclitaxel; Premedication; Retrospective Studies; Tertiary Care Centers | 2019 |
Re-exploring immune-related side effects of docetaxel in an observational study: Blood hypereosinophilia.
Topics: Antineoplastic Agents; Docetaxel; Drug Hypersensitivity; Eosinophilia; Humans; Leukocyte Count; Middle Aged | 2019 |
Treatment outcomes of rapid desensitisation protocols for chemotherapeutic agents and monoclonal antibodies following hypersensitivity reactions.
Topics: Aged; Aged, 80 and over; Anti-Allergic Agents; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Australian Capital Territory; Cisplatin; Desensitization, Immunologic; Docetaxel; Dose-Response Relationship, Immunologic; Drug Hypersensitivity; Female; Humans; Male; Medical Audit; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Premedication; Referral and Consultation; Retrospective Studies; Rituximab; Taxoids; Treatment Outcome | 2014 |
[Use of pertuzumab and docetaxel desensitization in oncological patient; apropos of a case].
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Desensitization, Immunologic; Docetaxel; Drug Hypersensitivity; Female; Humans; Middle Aged; Taxoids | 2014 |
[Safe treatment of lung squamous cell carcinoma with nanoparticle albumin-bound Paclitaxel in a patient with a previous hypersensitivity reaction after docetaxel administration].
Topics: Albumins; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Docetaxel; Drug Hypersensitivity; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Taxoids | 2015 |
Risk stratification and skin testing to guide re-exposure in taxane-induced hypersensitivity reactions.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Desensitization, Immunologic; Docetaxel; Drug Hypersensitivity; Female; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Paclitaxel; Retrospective Studies; Risk Assessment; Severity of Illness Index; Skin Tests; Taxoids; Treatment Outcome | 2016 |
A digestive allergic reaction with hypereosinophilia imputable to docetaxel in a breast cancer patient: a case report.
Topics: Adult; Antineoplastic Agents; Breast Neoplasms; Docetaxel; Drug Hypersensitivity; Eosinophilia; Female; Gastrointestinal Tract; Humans; Taxoids | 2015 |
[Clinical analysis of premedication regimen with dexamethasone at different doses for docetaxel-induced hypersensitivity reaction].
Topics: Aged; Antineoplastic Agents; Dexamethasone; Docetaxel; Dose-Response Relationship, Drug; Drug Hypersensitivity; Exanthema; Fever; Humans; Middle Aged; Neoplasms; Premedication; Taxoids | 2009 |
Single premedication dose of dexamethasone 20 mg IV before docetaxel administration.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Dexamethasone; Docetaxel; Drug Administration Schedule; Drug Hypersensitivity; Edema; Female; Glucocorticoids; Humans; Injections, Intravenous; Male; Middle Aged; Premedication; Retrospective Studies; Taxoids; Texas | 2011 |
Association of CYP1B1 with hypersensitivity induced by taxane therapy in breast cancer patients.
Topics: Aged; Antineoplastic Agents, Phytogenic; Aryl Hydrocarbon Hydroxylases; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Breast Neoplasms, Male; Chemotherapy, Adjuvant; Chi-Square Distribution; Cytochrome P-450 CYP1B1; Cytochrome P-450 CYP2C8; Cytochrome P-450 Enzyme System; Docetaxel; Drug Hypersensitivity; Female; Gene Frequency; Genetic Predisposition to Disease; Humans; Italy; Logistic Models; Male; Middle Aged; Neoadjuvant Therapy; Odds Ratio; Paclitaxel; Phenotype; Polymorphism, Single Nucleotide; Retrospective Studies; Risk Assessment; Risk Factors; Taxoids; Treatment Outcome | 2010 |
[Desensitisation to circumvent hypersensitivity reactions; treatment with docetaxel still possible].
Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Docetaxel; Dose-Response Relationship, Drug; Dose-Response Relationship, Immunologic; Drug Hypersensitivity; Female; Humans; Lung Neoplasms; Middle Aged; Taxoids | 2011 |
Hypersensitivity reactions to docetaxel: retrospective evaluation and development of a desensitization protocol.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Desensitization, Immunologic; Docetaxel; Drug Hypersensitivity; Female; Humans; Lung Neoplasms; Male; Middle Aged; Taxoids | 2011 |
Hypersensitivity reactions to anticancer agents: data mining of the public version of the FDA adverse event reporting system, AERS.
Topics: Adverse Drug Reaction Reporting Systems; Antineoplastic Agents; Asparaginase; Bayes Theorem; Data Mining; Docetaxel; Drug Hypersensitivity; Etoposide; Humans; Paclitaxel; Pharmacovigilance; Procarbazine; Prognosis; Taxoids; Teniposide; United States; United States Food and Drug Administration | 2011 |
Cross-sensitivity between taxanes in patients with breast cancer.
Topics: Adult; Aged; Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Dexamethasone; Docetaxel; Drug Hypersensitivity; Female; Follow-Up Studies; Humans; Middle Aged; Paclitaxel; Premedication; Retrospective Studies; Taxoids; Treatment Outcome | 2011 |
A shortened docetaxel desensitization protocol for use in special cases.
Topics: Antineoplastic Agents, Phytogenic; Desensitization, Immunologic; Docetaxel; Drug Hypersensitivity; Humans; Male; Middle Aged; Prostatic Neoplasms; Skin Tests; Taxoids | 2012 |
Successful desensitization to docetaxel after severe hypersensitivity reactions in two patients.
Topics: Adult; Antineoplastic Agents; Desensitization, Immunologic; Docetaxel; Drug Hypersensitivity; Female; Genital Neoplasms, Female; Humans; Middle Aged; Severity of Illness Index; Taxoids; Treatment Outcome | 2012 |
Taxus baccata allergy in a breast cancer patient.
Topics: Adult; Antineoplastic Agents; Breast Neoplasms; Docetaxel; Dose-Response Relationship, Immunologic; Drug Hypersensitivity; Female; Humans; Taxoids; Taxus | 2012 |
Unknown primary carcinoma: a feasibility assessment of combination chemotherapy with cisplatin and docetaxel.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Diarrhea; Docetaxel; Drug Hypersensitivity; Feasibility Studies; Female; Humans; Male; Middle Aged; Nausea; Neoplasms, Unknown Primary; Neutropenia; Paclitaxel; Patient Compliance; Prospective Studies; Severity of Illness Index; Taxoids; Treatment Outcome; Vomiting | 2003 |
Successful docetaxel tolerance induction.
Topics: Adult; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Desensitization, Immunologic; Docetaxel; Drug Hypersensitivity; Humans; Lung Neoplasms; Male; Taxoids | 2003 |
Non-allergic nature of docetaxel-induced acute hypersensitivity reactions.
Topics: Administration, Oral; Adult; Blood Pressure; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Deoxycytidine; Docetaxel; Doxorubicin; Drug Hypersensitivity; Female; Gemcitabine; Histamine; Histamine Antagonists; Humans; Hypersensitivity, Immediate; Infusions, Intravenous; Male; Methylprednisolone; Middle Aged; Paclitaxel; Premedication; Serine Endopeptidases; Tachycardia; Taxoids; Time Factors; Tryptases | 2004 |
[Docetaxel and carboplatin for epithelial ovarian cancer].
Topics: Adult; Aged; Aged, 80 and over; Alopecia; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Dexamethasone; Docetaxel; Drug Administration Schedule; Drug Evaluation; Drug Hypersensitivity; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukopenia; Middle Aged; Neutropenia; Ovarian Neoplasms; Taxoids | 2004 |
Advances in taxane therapy for metastatic breast cancer.
Topics: Antineoplastic Agents, Phytogenic; Bone Marrow; Breast Neoplasms; Chemistry, Pharmaceutical; Docetaxel; Drug Hypersensitivity; Heart Diseases; Humans; Nausea; Paclitaxel; Taxoids; Treatment Outcome; Vomiting; Water-Electrolyte Imbalance | 2004 |
Acute interstitial pneumopathy associated with docetaxel hypersensitivity.
Topics: Acute Disease; Aged; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Ductal; Docetaxel; Dose-Response Relationship, Drug; Drug Hypersensitivity; Female; Humans; Lung Diseases, Interstitial; Taxoids | 2004 |
Rapid desensitization for hypersensitivity reactions to paclitaxel and docetaxel: a new standard protocol used in 77 successful treatments.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Desensitization, Immunologic; Docetaxel; Drug Hypersensitivity; Female; Genital Neoplasms, Female; Humans; Middle Aged; Paclitaxel; Taxoids | 2005 |
Cross-sensitivity between paclitaxel and docetaxel in a women's cancers program.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Docetaxel; Drug Hypersensitivity; Female; Genital Neoplasms, Female; Humans; Paclitaxel; Retrospective Studies; Taxoids | 2006 |
Successful docetaxel rechallenge with cromoglycate after major sensitivity reactions.
Topics: Administration, Oral; Anti-Asthmatic Agents; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cromolyn Sodium; Docetaxel; Drug Hypersensitivity; Female; Humans; Middle Aged; Paclitaxel; Taxoids | 1996 |
[Acute diffuse interstitial pneumopathy following docetaxel (Taxotère). Apropos of 2 cases].
Topics: Aged; Alveolitis, Extrinsic Allergic; Anti-Inflammatory Agents; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Docetaxel; Drug Hypersensitivity; Glucocorticoids; Humans; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Male; Paclitaxel; Prednisolone; Pulmonary Edema; Taxoids | 1998 |
Paclitaxel hypersensitivity reactions: a role for docetaxel substitution.
Topics: Aged; Antineoplastic Agents, Phytogenic; Docetaxel; Drug Hypersensitivity; Female; Glycerol; Humans; Male; Middle Aged; Neoplasms; Paclitaxel; Taxoids | 1998 |
Use of docetaxel (Taxotere) in patients with paclitaxel (Taxol) hypersensitivity.
Topics: Adult; Antineoplastic Agents, Phytogenic; Carcinoma; Cimetidine; Cystadenocarcinoma; Dexamethasone; Diphenhydramine; Docetaxel; Drug Administration Schedule; Drug Hypersensitivity; Drug Therapy, Combination; Female; Humans; Middle Aged; Ovarian Neoplasms; Paclitaxel; Taxoids | 2000 |
Hypersensitivity reaction (HSR) to docetaxel after a previous HSR to paclitaxel.
Topics: Antineoplastic Agents, Phytogenic; Docetaxel; Drug Hypersensitivity; Female; Humans; Middle Aged; Paclitaxel; Taxoids | 2002 |